Zucker v. Sable

426 F. Supp. 658
CourtDistrict Court, S.D. New York
DecidedOctober 9, 1976
Docket74 Civ. 1086 (HFW)
StatusPublished
Cited by5 cases

This text of 426 F. Supp. 658 (Zucker v. Sable) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Zucker v. Sable, 426 F. Supp. 658 (S.D.N.Y. 1976).

Opinion

OPINION

WERKER, District Judge.

Plaintiff suing for himself and on behalf of others similarly situated seeks to recover damages for alleged misstatements and omissions by the defendants in a press release that dealt with the development of soft contact lenses. This court has jurisdiction of the action pursuant to 28 U.S.C. § 1331 and Section 27 of the Securities Exchange Act of 1934. The defendants have moved to dismiss the amended complaint and for judgment on the pleadings.

The defendants assert that the complaint should be dismissed as insufficient as a matter of law for plaintiff’s failure to allege a purchase or sale of securities by the defendant. There has been no showing that the defendants did in fact buy or sell securities. However, section 10b, 15 U.S.C. § 78j(b), is violated where assertions are made in a manner reasonably calculated to influence the investing community if such assertions are false or misleading or are so incomplete as to mislead irrespective of whether the issuance of the release was motivated by corporate officials for ulterior purposes. The term “in connection with” in rule 10b-5 should be construed broadly to include a device that would cause an investor to purchase or sell a corporation’s securities. Securities & Exchange Commission v. Texas Gulf Sulphur Co., 401 F.2d 833 (2d Cir. 1968) (en banc), cert. denied, 394 U.S. 976, 89 S.Ct. 1454, 22 L.Ed.2d 756 (1969), on remand, 312 F.Supp. 77 (S.D.N.Y.1970), modified, 446 F.2d 1301 (2d Cir.), cert. denied, 404 U.S. 1005, 92 S.Ct. 561, 30 L.Ed.2d 558 (1971).

There is no requirement of contemporaneous trading in securities by insiders or by *660 the corporation itself. Heit v. Weitzen, 402 F.2d 909 (2d Cir. 1968), cert. denied, 395 U.S. 903, 89 S.Ct. 1740, 23 L.Ed.2d 217 (1969). Since there are allegations that the plaintiff relied on the statements and in reliance did buy shares of Union stock, the purchase/sale requirement has been met.

The dispute in this action centers on the issuance by the defendants of a press release announcing the filing of an investigational new drug application with the Food and Drug Administration (FDA). Union, the corporate defendant was involved in the development of a water absorbing, plastic material for use in manufacturing soft contact lenses. The plaintiff alleges that it may take as long as several years from the time an investigational new drug application is filed until the product is approved for sale in the public market. The claim upon which this action is based is that the defendants were obligated to include this information in their press release and that the failure to do so resulted in the omission of material information in violation of rule 10b-5. The plaintiff also charges that the defendants failed to correct reports of the press release in various financial journals which omitted the word “investigational” in reporting the announcement by the company. Finally the plaintiff alleges “other actions” by the defendants that were calculated to create a false impression that the defendants were currently involved in the manufacture of soft contact lenses when in fact any entry into that market was several years away.

The plaintiff seeks recovery for the defendants’ failure to include in the press release information concerning the FDA’s procedures and processing time for investigational new drug applications. The defendants assert that rule 10b-5 does not impose any obligation to disclose public information which was equally available to the plaintiffs and the defendants.. The plaintiff argues that the subject matter of the release is highly technical and is beyond the reach of the ordinary investor.

This appears to be a case of first impression on this issue. The cases cited to the court are not directly on point. For example, in Hafner v. Forest Laboratories, Inc., 345 F.2d 167 (2d Cir. 1965), a case cited by the defendants, the court held that failure to disclose the market price of certain shares of stock was not a violation of section 10b. In that case, the plaintiff had an agreement with the defendant corporation that the corporation would, upon plaintiff’s request, either seek to register the shares which the plaintiff held or would purchase back the shares for $1.75 per share. In connection with the exercise of the option, the plaintiff asked the corporation what was the current market price of the shares which were being traded in the over-the-counter market. The defendant- failed to provide the information, but the plaintiff went ahead and sold the shares to the corporation. In a suit for rescission and damages, the plaintiff alleged a section 10b violation by the corporation in failing to disclose the material information, the market price of the shares, which the plaintiff had sought. The court dismissed the complaint and found that where the corporation did not misrepresent the market price and where that information was readily available in the pink sheets, there was no 10b violation.

Another case relied on by the defendants is Frigitemp Corp. v. Financial Dynamics Fund, Inc., 524 F.2d 275 (2d Cir. 1975). In that case, mutual funds purchased from Frigitemp a $1,000,000 convertible subordinated debenture and warrants to purchase common stock without disclosing to the corporation or its principal shareholders that the funds already owned a substantial amount of Frigitemp’s publicly owned common stock and that they intended to purchase most of the public float. As a condition of the private placement, the funds had required the principal shareholders to contribute 100,000 shares of their common stock to the capital of the corporation. The court held that there was no obligation to inform the corporation that the companies purchasing the convertible debentures were also shareholders. Furthermore, the court held that there was no duty to disclose *661 information to which the corporation had access. The court also held that a “party charged with failing to disclose market information must be under a duty to disclose it to the plaintiffs.” Id. at 282.

The defendants also rely on Myzel v. Fields, 386 F.2d 718 (8th Cir. 1967), cert. denied, 390 U.S. 951, 88 S.Ct. 1043, 19 L.Ed.2d 1143 (1968). But the portion of the opinion on which the defendants rely deals with the sale of stock by an insider to another insider.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
426 F. Supp. 658, Counsel Stack Legal Research, https://law.counselstack.com/opinion/zucker-v-sable-nysd-1976.